Project Details
Short title | A Phase II, Randomised, Double-blind, Parallel Group Study to Assess the Efficacy of AZD2171 45mg Versus Placebo following 12 Weeks of Treatment in Patients with Metastatic or Recurrent Renal Cell Carcinoma who have had no Previous Anti-VE |
---|---|
Status | Finished |
Effective start/end date | 14/11/06 → 31/07/12 |
Funding
- Queen Elizabeth Hospital Birmingham